Respiratory Tract Infections
📧 Sign up to get email alerts when something new happens for Respiratory Tract Infections.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-28FDA Approved: DOXYCYCLINE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' generic doxycycline as an Original Application (ANDA 218053), enabling market entry of a doxycycl…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: ADEQUATE Advanced Diagnostics for Enhanced Quality of Antibiotic Prescription [NA]
The ADEQUATE trial evaluating advanced diagnostics to improve antibiotic prescribing for respiratory tract infections was terminated, and re…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated from Patients with Hospital Acquired Infections in Sohag University Hospitals, Egypt
Clinical trial evaluating the antibacterial effect of zinc oxide nanoparticles against Acinetobacter baumannii isolated from hospital-acquir…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens [NA]
Completed safety and acceptability trial of the RD19 device intended to protect against human respiratory disease pathogens; results have be…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Patient Portal Flu Vaccine Reminders (5) [NA]
Clinical trial update on a patient portal reminder system for flu vaccination; the study is completed and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Transmission Of Respiratory Tract microOrganisms In a School Environment
A completed clinical trial from Leiden University Medical Center investigating the transmission of respiratory tract microorganisms in a sch…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Novel Mucosal Correlates Of RSV Protection In Older Adults [NA]
Clinical trial update describing recruitment for a study investigating mucosal correlates of protection against Respiratory Syncytial Virus …
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant [Phase 1, Phase 2]
A Phase 1/2 study of ALVR106 in patients with respiratory tract viral infections after hematopoietic cell or solid organ transplantation was…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Beetroot Juice NO Cold Study [Phase 2]
Phase 2 clinical trial evaluating beetroot juice for reducing cold symptoms and impact on exhaled nitric oxide in individuals with respirato…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Virus Interactions in the Respiratory Tract; a Cohort Study With Children
A completed pediatric cohort study examining how viruses interact in the respiratory tract and how coinfections influence disease dynamics.
-
FDA approval · 2024-03-14FDA Approved: DOXYCYCLINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for doxycycline, a generic antibiotic, expanding the availability of doxycycline pr…
-
EMA approval · 2023-12-13EMA Authorised: Vantobra (previously Tobramycin PARI) (tobramycin) — Pari Pharma GmbH
EMA has authorised Vantobra (tobramycin) for respiratory tract infections including cystic fibrosis, with Pari Pharma GmbH as the marketing …
-
FDA approval · 2023-10-31FDA Approved: AMPICILLIN — Original Application (Aurobindo Pharma Limited)
FDA approved an original application for Ampicillin from Aurobindo Pharma Limited, granting marketing authorization for a generic ampicillin…
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the immunogenicity, efficacy, and safety of the Convacell vaccine in healthy adults aged 18 and older …
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly [Phase 3]
Phase 3 trial evaluating a plant-derived quadrivalent virus-like particle (VLP) vaccine in elderly populations has completed with results po…
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age [Phase 1, Phase 2]
A Phase 1/2 study evaluating the safety, tolerability and immunogenicity of the investigational RSV vaccine candidate Ad26.RSV.preF in adult…
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit? [Phase 3]
Phase 3 trial evaluating antibiotic efficacy in children with acute sinusitis and identifying subgroups that benefit.
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Targeted AntiBiotics for Chronic Pulmonary Diseases [Phase 4]
Phase 4 clinical trial update for targeted antibiotics in chronic pulmonary diseases has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO) [Phase 1, Phase 2]
Phase 1/2 trial update on safety and tolerability of high-dose rifapentine with isoniazid for latent TB infection in HIV+ patients, compared…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- UCLA Portal R/R Influenza RCT 3 [NA]
A completed randomized trial from UCLA evaluated patient portal reminders/recalls to boost influenza vaccination uptake within a health syst…
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults [Phase 4]
Phase 4 trial updating prevention of respiratory tract infections and Covid-19 through BCG vaccination in vulnerable older adults has been c…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 [Phase 1, Phase 2]
Clinical trial update for CYNK-001 natural killer cell infusions in adults with COVID-19, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Cod Liver Oil for Covid-19 Prevention Study [Phase 4]
A Phase 4 clinical trial investigating cod liver oil for prevention of Covid-19 and respiratory tract infections has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI) [Phase 4]
Phase 4 trial evaluating pidotimod in children for recurrent respiratory tract infections has been completed.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Patient Portal - Flu Reminder Recall [NA]
Clinical trial update for a patient portal reminder recall related to influenza and respiratory tract infections; study completed with resul…